Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dulcolax for Anorectal Dysfunction in Multiple Sclerosis
NCT02609607Phase 2Terminated
- Start
- Jun 2016
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in constipation and fecal incontinence (FI) comparing Placebo Arm with Bisacodyl Arm (2 arms). Primary endpoint: Number of Participants With 30% Improvement From Baseline in Bowel Symptoms at 4 weeks. Started Jun 2016; status: terminated.
02
Drugs
bisacodyl
03
Conditions
constipationfecal incontinence (FI)
Beyond the preview
Go deeper on NCT02609607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02609607.